FDA-compliant qualification of manufacturing plants for active pharmaceutical ingredients

被引:0
|
作者
Gengenbach, R [1 ]
机构
[1] Gempex GmbH, Mannheim, Germany
来源
PHARMAZEUTISCHE INDUSTRIE | 2003年 / 65卷 / 07期
关键词
D O I
暂无
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Qualification of pharmaceutical production plants nowadays being an essential quality assurance element is urgently required in the GMP (Good Manufacturing Practice) regulations. But nevertheless, many people still do not know exactly how to proceed, especially how to incorporate the various activities in the planning and building of intricate plants. The following article, after dealing briefly with regulatory requirements and explaining the most important terminology, depicts the individual steps such as DQ (Design Qualification), IQ (Installation Qualification), OQ (Operational Qualification), PQ (Performance Qualification), calibration, and maintenance in detail. The corresponding test items are listed and illustrated with the aid of specific examples. The article particularly focusses on the typical process performed for new plants, and shows a way to integrated plant qualification. Finally, qualification of already existing production plants is also described briefly.
引用
下载
收藏
页码:704 / 711
页数:8
相关论文
共 50 条
  • [21] Towards continuous flow manufacturing of active pharmaceutical ingredients in Africa: a perspective
    Nqeketo, Sinazo
    Sagandira, Cloudius R.
    REACTION CHEMISTRY & ENGINEERING, 2024, 9 (10): : 2532 - 2551
  • [22] Influence of Manufacturing Technology on the Properties of Active Pharmaceutical Ingredients of Prostate Extract
    Savel'ev, S. A.
    Dorosh, M. Yu
    Oparina, T., I
    Lagereva, I. A.
    Chepanov, S., V
    Tsymbalova, O. A.
    Myl'nikov, S., V
    Sel'kov, S. A.
    PHARMACEUTICAL CHEMISTRY JOURNAL, 2022, 56 (03) : 403 - 410
  • [23] Polymorphism of active pharmaceutical ingredients
    Karpinski, PH
    CHEMICAL ENGINEERING & TECHNOLOGY, 2006, 29 (02) : 233 - 237
  • [24] Current good manufacturing practice design trends in active pharmaceutical ingredients facilities
    Angelucci, LA
    DRUG INFORMATION JOURNAL, 1999, 33 (03): : 739 - 746
  • [25] Theoretical approaches to physical transformations of active pharmaceutical ingredients during manufacturing processes
    Morris, KR
    Griesser, UJ
    Eckhardt, CJ
    Stowell, JG
    ADVANCED DRUG DELIVERY REVIEWS, 2001, 48 (01) : 91 - 114
  • [26] Synthetic challenges in the development of commercial manufacturing processes for two active pharmaceutical ingredients
    Savage, Scott
    Domagalski, Nathan
    Hobson, Lindsay
    Jones, Scott
    Mack, Brendan
    Qiu, Yuping
    Ramirez, Antonio
    Waltermire, Robert
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2016, 252
  • [27] Continuous-Flow TechnologyA Tool for the Safe Manufacturing of Active Pharmaceutical Ingredients
    Gutmann, Bernhard
    Cantillo, David
    Kappe, C. Oliver
    ANGEWANDTE CHEMIE-INTERNATIONAL EDITION, 2015, 54 (23) : 6688 - 6728
  • [28] Current Good Manufacturing Practice Design Trends in Active Pharmaceutical Ingredients Facilities
    Louis A. Angelucci
    Drug information journal : DIJ / Drug Information Association, 1999, 33 : 739 - 746
  • [29] A RISK-BASED APPROACH TO MANAGING ACTIVE PHARMACEUTICAL INGREDIENTS IN MANUFACTURING EFFLUENT
    Caldwell, Daniel J.
    Mertens, Birgit
    Kappler, Kelly
    Senac, Thomas
    Journel, Romain
    Wilson, Peter
    Meyerhoff, Roger D.
    Parke, Neil J.
    Mastrocco, Frank
    Mattson, Bengt
    Murray-Smith, Richard
    Dolan, David G.
    Straub, Juerg Oliver
    Wiedemann, Michael
    Hartmann, Andreas
    Finan, Douglas S.
    ENVIRONMENTAL TOXICOLOGY AND CHEMISTRY, 2016, 35 (04) : 813 - 822
  • [30] Prequalification of active pharmaceutical ingredients
    WHO EXPERT COMMITTEE ON SPECIFICATIONS FOR PHARMACEUTICAL PREPARATIONS, 2015, 992 : 37 - 37